Ormeloxifene versus Medroxyprogesterone Acetate (MPA) in the Treatment of Dysfunctional Uterine Bleeding: A Double-Blind Randomized Controlled Trial
MB Bellad, D Mekhala, Jyotsna Shravage, MS Ganachari, HA Dhumale
Citation Information :
Bellad M, Mekhala D, Shravage J, Ganachari M, Dhumale H. Ormeloxifene versus Medroxyprogesterone Acetate (MPA) in the Treatment of Dysfunctional Uterine Bleeding: A Double-Blind Randomized Controlled Trial. J South Asian Feder Obs Gynae 2011; 3 (1):21-24.
Oestrogens and progestogens in clinical practice, Chapter 35 “ Dysfunctional Uterine Bleeding”. Church II Living Stone Publication 1998;419-37.
The evaluation of abnormal uterine bleeding. Clinical obstetrics and gynecology 2005;48(2):382-97.
Cyclical progestogens for heavy menstrual bleeding. Cochrane database of systematic reviews 2008 (Issue 1). Art No CD001016. DOI: 10.1002/ 14651858.cd001016. pub.
Ormeloxifene: A selective estrogen receptor modulator for treatment of dysfunctional menorrhagia. J Obstet Gynecol Ind 2004;54(1):56-59.
Clinical management guidelines for obstetricians and gynecologists 2002;39(4):835-44.
Robert B Selective oestrogen receptor modulators: An update on recent clinical findings. Obstetrical and gynecological survey Mar 2008;63(3):163-81.
Clinical gynecologic endocrinology and infertility, Chapter 15 “Dysfunctional Uterine Bleeding” (7th ed). Lipcott Williams and Willkins 2005;547-73.
Assessment of medical treatment for menorrhagia. Br J Obst and Gynecol Jul 1994;101 (Suppl 11):15-18.
Progress in obstetrics and gynecology, Chapter 17 “Abnormal uterine bleeding: Diagnosis and medical management”. Churchill living stone 2003;12:309-27.
Mechanism of abnormal uterine bleeding. Human reprod update 2002;8(1):60-67.
Nonsteroidal anti-inflammatory drugs for heavy menstrual bleeding. Cochrane database of systematic reviews 2007 (Issue 4). Art No CD00400: DOI: 10.1002/14651858 Pub 2.
Prasad S A novel drug for DUB J. Obstet Gynecol India 2000;50:77-79.
Dysfunctional uterine bleeding. In: Whitefield CR (Ed). Dewhursts textboon of obstetrics and gynecology for postgraduates (5th ed). London: Blackwell Scientific 1995;509.
Efficacy and safety of ormeloxifene in the management of menorrhagia: A pilot study. The journal of obstetrics and gynecol research 2009;35(4): 746-52.
Assessment of menstrual blood loss using a pictorial chart. British journal of obstetrics and gynecology 1990;97:734-39.
A simple visual assessment technique to discriminate between monorrhagia and normal menstrual blood loss. Obstetrics and gynecology 1995;85(6):977-82.
